Alex Gough
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alex Gough has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alice Sitch
Department of Applied Health Sciences, University of Birmingham, UK; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, UK
6 shared publicationsTom Marshall
Department of Applied Health Sciences, University of Birmingham, Birmingham, UK
5 shared publicationsErica Ferris
Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom
2 shared publications- Tom Marshall
Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
2 shared publications - Alice Margaret Turner
Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
1 shared publication - Alice Sitch
Institute of Applied Health Research, University of Birmingham, Birmingham, UK
1 shared publication
Latest Publications
- 2 October 2026
- Published by Mark Allen Group in Companion Animal
- Vol. 31 (4) , 206
Small animal review
Dietary supplements are commonly recommended for aiding in the treatment of various conditions in dogs. However, the evidence for efficacy in many cases is often weak or absent, and although they are often considered harmless, safety data may also be lacking. Three recent studies help increase the evidence base for the use of different supplements for various health-related purposes in dogs.
- 2 October 2026
- Published by Mark Allen Group in Companion Animal
- Vol. 31 (4) , 206
Small animal review
Dietary supplements are commonly recommended for aiding in the treatment of various conditions in dogs. However, the evidence for efficacy in many cases is often weak or absent, and although they are often considered harmless, safety data may also be lacking. Three recent studies help increase the evidence base for the use of different supplements for various health-related purposes in dogs.
- Open Access
- 1 August 2026
- Published by Springer Nature in Trials
- Vol. 27 (1)
Reporting of justifications for withholding established effective interventions in randomised placebo-controlled trials: a systematic review
- 1 August 2026
- Published by Springer Nature in Trials
- Vol. 27 (1)
Open AccessReporting of justifications for withholding established effective interventions in randomised placebo-controlled trials: a systematic review
- Open Access
- 17 May 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e003853
Within-individual variation of spirometry measurements in primary care: a retrospective cohort study
Background: Forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) are two of the most common measurements in spirometry, which are used for the diagnosis and monitoring of respiratory disease. Within-individual variation in measured FEV 1 and FVC may affect their clinical utility but estimates of this are based on limited and often poor-quality data. Methods: A retrospective cohort study was performed. Data on FEV 1 and FVC results and sociodemographic, lifestyle and comorbidity covariates were extracted from the IQVIA Medical Research Database. A minimum of four measurements in the same individual within a 6-month time period from the first measurement was the only inclusion criterion. Within-individual measured variation was calculated as a coefficient of variation (CV) using a linear regression random effects model using within-subject variance to estimate CV for the whole population and various subgroups. Results: 4412 participants for FEV 1 and 3567 participants for FVC were included in the main study. The mean number of measurements per individual in the 6-month period was 4.8 (SD 2.3) for FEV 1 and 5.1 (SD 3.5) for FVC. The overall CV for FEV 1 was 22.4% (95% CI 22.1% to 22.8%) and for FVC was 15.2% (95% CI 15.0% to 15.5%). This is much higher than seen in a previous systematic review of spirometry variation. CV increased as mean patient FEV 1 and FVC decreased. Conclusions: Estimated within-individual variation in this analysis of real-world data is much higher than previously reported. Variation increases with more severe disease status. This has important implications for diagnosis, monitoring and clinical decision-making.
- 17 May 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e003853
Open AccessWithin-individual variation of spirometry measurements in primary care: a retrospective cohort study
Background: Forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) are two of the most common measurements in spirometry, which are used for the diagnosis and monitoring of respiratory disease. Within-individual variation in measured FEV 1 and FVC may affect their clinical utility but estimates of this are based on limited and often poor-quality data. Methods: A retrospective cohort study was performed. Data on FEV 1 and FVC results and sociodemographic, lifestyle and comorbidity covariates were extracted from the IQVIA Medical Research Database. A minimum of four measurements in the same individual within a 6-month time period from the first measurement was the only inclusion criterion. Within-individual measured variation was calculated as a coefficient of variation (CV) using a linear regression random effects model using within-subject variance to estimate CV for the whole population and various subgroups. Results: 4412 participants for FEV 1 and 3567 participants for FVC were included in the main study. The mean number of measurements per individual in the 6-month period was 4.8 (SD 2.3) for FEV 1 and 5.1 (SD 3.5) for FVC. The overall CV for FEV 1 was 22.4% (95% CI 22.1% to 22.8%) and for FVC was 15.2% (95% CI 15.0% to 15.5%). This is much higher than seen in a previous systematic review of spirometry variation. CV increased as mean patient FEV 1 and FVC decreased. Conclusions: Estimated within-individual variation in this analysis of real-world data is much higher than previously reported. Variation increases with more severe disease status. This has important implications for diagnosis, monitoring and clinical decision-making.
- 2 April 2026
- Published by Mark Allen Group in Companion Animal
- Vol. 31 (2) , 102
Small animal review
These recent studies examine factors affecting canine health, owner decision-making and recognition of pain in dogs. Early-life conditions at the time of purchase were linked to increased health problems and higher veterinary costs in young dogs. Pet insurance uptake was influenced by income and cost, while emotional attachment played a key role in willingness to pay for treatment. Although owners could identify behavioural signs of pain, their assessments often differed from those of veterinarians, highlighting a need for improved owner education.
- 2 April 2026
- Published by Mark Allen Group in Companion Animal
- Vol. 31 (2) , 102
Small animal review
These recent studies examine factors affecting canine health, owner decision-making and recognition of pain in dogs. Early-life conditions at the time of purchase were linked to increased health problems and higher veterinary costs in young dogs. Pet insurance uptake was influenced by income and cost, while emotional attachment played a key role in willingness to pay for treatment. Although owners could identify behavioural signs of pain, their assessments often differed from those of veterinarians, highlighting a need for improved owner education.
- Open Access
- 1 February 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 401, 121246
Within-individual variation of depression symptom measurement instruments in primary care: a retrospective cohort study
- 1 February 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 401, 121246
Open AccessWithin-individual variation of depression symptom measurement instruments in primary care: a retrospective cohort study
- 2 January 2026
- Published by Mark Allen Group in Companion Animal
- Vol. 31 (1) , 50
Small animal review
Recent feline cardiology studies emphasise advances in diagnostic assessment despite ongoing challenges. Tissue Doppler echocardiography confirms frequent systolic and diastolic dysfunction in cats with hypertrophic cardiomyopathy, although prognostic value remains limited by small study sizes. A 9-lead electrocardiogram system improves evaluation of atrial and ventricular depolarisation without age-related effects. Reference ranges for aortic root size in healthy cats indicate that body weight and age should be considered when interpreting echocardiographic measurements.
- 2 January 2026
- Published by Mark Allen Group in Companion Animal
- Vol. 31 (1) , 50
Small animal review
Recent feline cardiology studies emphasise advances in diagnostic assessment despite ongoing challenges. Tissue Doppler echocardiography confirms frequent systolic and diastolic dysfunction in cats with hypertrophic cardiomyopathy, although prognostic value remains limited by small study sizes. A 9-lead electrocardiogram system improves evaluation of atrial and ventricular depolarisation without age-related effects. Reference ranges for aortic root size in healthy cats indicate that body weight and age should be considered when interpreting echocardiographic measurements.
- 2 December 2025
- Published by Mark Allen Group in Companion Animal
- Vol. 30 (12) , 206
Small animal review
The problems associated with foreign body ingestion such as gastrointestinal obstruction are among the most common indications for gastrotomy and enterotomy. Three recent papers discuss this situation and interventions for management.
- 2 December 2025
- Published by Mark Allen Group in Companion Animal
- Vol. 30 (12) , 206
Small animal review
The problems associated with foreign body ingestion such as gastrointestinal obstruction are among the most common indications for gastrotomy and enterotomy. Three recent papers discuss this situation and interventions for management.
- Open Access
- 24 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0337221
Within-individual variation of C-reactive protein (CRP) measurements in primary care: A retrospective cohort study
Background: C-reactive protein (CRP) is a biomarker of inflammation used in diagnosis of inflammatory diseases and to guide treatment decisions. Variation in within-individual measured CRP may affect its clinical utility but estimates of within-individual variation are based on limited data and so may not be accurate. Methods: A retrospective cohort study was performed using data on CRP results and sociodemographic, lifestyle and comorbidity covariates extracted from the IQVIA Medical Research Database (IMRD) database using the DEXTER tool. A minimum of four measurements for each individual was the only inclusion criterion. CRP data were log-transformed for analysis. Within-individual measured variation was calculated as a coefficient of variation (CV) using a linear regression random effects model for the whole population and various subgroups. Results: 472,811 participants were included in this study, making it the largest study of variation of CRP to date by a factor of approximately five. The overall coefficient of variation for CRP was 1.604 (95% CI 1.602 to 1.606). This is much higher than the median reported CV for CRP of previous studies which was 0.41. CV increased with patient median. Strengths and limitations: The large number of participants and the real-world nature of the results are important strengths of this study. Weaknesses included the problem of accounting for confounding by indication, and the short half-life of CRP making it hard to distinguish between acute illness and physiological variation. Conclusions: Estimated within-individual variation in this analysis of real-world data is very high and is higher than previously reported. Variation increases with patient median CRP, that is with more severe disease status. This has important implications for the diagnosis, monitoring and clinical decision-making for inflammatory disease.
- 24 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0337221
Open AccessWithin-individual variation of C-reactive protein (CRP) measurements in primary care: A retrospective cohort study
Background: C-reactive protein (CRP) is a biomarker of inflammation used in diagnosis of inflammatory diseases and to guide treatment decisions. Variation in within-individual measured CRP may affect its clinical utility but estimates of within-individual variation are based on limited data and so may not be accurate. Methods: A retrospective cohort study was performed using data on CRP results and sociodemographic, lifestyle and comorbidity covariates extracted from the IQVIA Medical Research Database (IMRD) database using the DEXTER tool. A minimum of four measurements for each individual was the only inclusion criterion. CRP data were log-transformed for analysis. Within-individual measured variation was calculated as a coefficient of variation (CV) using a linear regression random effects model for the whole population and various subgroups. Results: 472,811 participants were included in this study, making it the largest study of variation of CRP to date by a factor of approximately five. The overall coefficient of variation for CRP was 1.604 (95% CI 1.602 to 1.606). This is much higher than the median reported CV for CRP of previous studies which was 0.41. CV increased with patient median. Strengths and limitations: The large number of participants and the real-world nature of the results are important strengths of this study. Weaknesses included the problem of accounting for confounding by indication, and the short half-life of CRP making it hard to distinguish between acute illness and physiological variation. Conclusions: Estimated within-individual variation in this analysis of real-world data is very high and is higher than previously reported. Variation increases with patient median CRP, that is with more severe disease status. This has important implications for the diagnosis, monitoring and clinical decision-making for inflammatory disease.
- Open Access
- 3 October 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (10) , e0333438
Within-individual variation of HbA1c measurements in primary care: A retrospective cohort study
Background: HbA1c is a marker for diabetes mellitus that reflects average glucose concentrations over the previous eight to twelve weeks. It is used to aid in the diagnosis and management of diabetes. Variation in within-individual measured HbA1c may affect its clinical utility but estimates of this are based on limited data that is often not generalisable to real-world settings. Methods: A retrospective cohort study was performed using data on HbA1c results and sociodemographic, lifestyle and comorbidity covariates extracted from the IQVIA Medical Research Database (IMRD) database using the DEXTER tool. A minimum of four measurements in the same individual was the only inclusion criterion. Within-individual measured variation was calculated as a coefficient of variation (CV) using a linear regression random effects model for the whole population and various subgroups. Results: 587,023 participants were included in this study, making it the largest study of variation of HbA1c to date. The overall measured within-individual coefficient of variation (CVT) was 0.20 (95%CI 0.20 to 0.20). This is around three times higher than reported in a previous systematic review. CVT increased with patient mean HbA1c level. Strengths and limitations: The large number of participants and the real-world nature of the results are important strengths of this study. Weaknesses included the problem of accounting for confounding by indication. Conclusions: Estimated within-individual variation in this analysis of real-world data is very high and is higher than previously reported. Variation increases with patient mean HbA1c, that is with more severe disease status. This has important implications for the diagnosis, monitoring and clinical decision-making for diabetes.
- 3 October 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (10) , e0333438
Open AccessWithin-individual variation of HbA1c measurements in primary care: A retrospective cohort study
Background: HbA1c is a marker for diabetes mellitus that reflects average glucose concentrations over the previous eight to twelve weeks. It is used to aid in the diagnosis and management of diabetes. Variation in within-individual measured HbA1c may affect its clinical utility but estimates of this are based on limited data that is often not generalisable to real-world settings. Methods: A retrospective cohort study was performed using data on HbA1c results and sociodemographic, lifestyle and comorbidity covariates extracted from the IQVIA Medical Research Database (IMRD) database using the DEXTER tool. A minimum of four measurements in the same individual was the only inclusion criterion. Within-individual measured variation was calculated as a coefficient of variation (CV) using a linear regression random effects model for the whole population and various subgroups. Results: 587,023 participants were included in this study, making it the largest study of variation of HbA1c to date. The overall measured within-individual coefficient of variation (CVT) was 0.20 (95%CI 0.20 to 0.20). This is around three times higher than reported in a previous systematic review. CVT increased with patient mean HbA1c level. Strengths and limitations: The large number of participants and the real-world nature of the results are important strengths of this study. Weaknesses included the problem of accounting for confounding by indication. Conclusions: Estimated within-individual variation in this analysis of real-world data is very high and is higher than previously reported. Variation increases with patient mean HbA1c, that is with more severe disease status. This has important implications for the diagnosis, monitoring and clinical decision-making for diabetes.
- 2 June 2025
- Published by Mark Allen Group in Companion Animal
- Vol. 30 (6) , 102
Small animal review
Chronic kidney disease is very common in older cats, and poses challenges to the clinician because of difficulties of early diagnosis and limited effective treatment options.
- 2 June 2025
- Published by Mark Allen Group in Companion Animal
- Vol. 30 (6) , 102
Small animal review
Chronic kidney disease is very common in older cats, and poses challenges to the clinician because of difficulties of early diagnosis and limited effective treatment options.